Hormonal Imbalances: Low testosterone in men or estrogen dominance/menopause in women
How It Works in Research It activates GIP, GLP-1, and glucagon receptors in your body - making you feel fuller longer, helping your body use insulin more effectively, and increasing your metabolic rate to burn more calories throughout the day
Cardiovascular outcome trials (CVOTs) of GLP-1RAs To date, the REWIND study has demonstrated for the first time that primary cardiovascular prevention strategies can significantly reduce cardiovascular adverse events in patients with T2DM, regardless of whether or not these patients are co-diagnosed with CVD [23]
J Neuroinflammation 16(1):242 Sheahan KH, Wahlberg EA, Gilbert MP (2020) An overview of GLP-1 agonists and recent cardiovascular outcomes trials
Generally speaking, the abdomen may feel less painful for some users, especially if theres a bit more subcutaneous fat
In a recent trial studying the effectiveness of tirzepatide (Zepbound) for weight loss, participants lost an average of 20.9% of their body weight at 36 weeks
